Advanced search
Start date

Investigation of CD4 and CD8 T cells profiles using multicolour flow cytometry to biomarkers identification on latent tuberculosis

Grant number: 21/01496-6
Support Opportunities:Scholarships in Brazil - Master
Effective date (Start): April 01, 2021
Effective date (End): March 31, 2023
Field of knowledge:Health Sciences - Collective Health - Public Health
Principal Investigator:Paula Ordonhez Rigato
Grantee:Bárbara Suéllen Guimarães Marin Ferreira
Host Institution: Instituto Adolfo Lutz (IAL). Coordenadoria de Controle de Doenças (CCD). Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil
Associated research grant:17/50333-7 - Institutional research development plan of the Instituto Adolfo Lutz (PDIp), AP.PDIP


The World Health Organization has established goals for eliminating tuberculosis (TB) epidemic by 2035. Tuberculosis is a contagious, airborne infectious disease, with mainly pulmonary involvement and can affect other organs. TB is a treatable disease if it is properly diagnosed. To fight TB, it is essential to search for strategies for early detection and treatment of the disease in the stages of high transmissibility. There are many difficulties in fighting against TB, including the bacillus multidrug-resistance, tuberculosis-HIV co-infection, diabetes, confinement of people (prison systems), poverty, malnutrition, and, mainly, the difficulty of diagnosing latent TB patients. For diagnosis of active (pulmonary) TB, there are diagnostic that includes the patient's anamnesis, imaging, and microbiological laboratory tests. On the other hand, latent TB is asymptomatic, but it can be diagnosed in the laboratory using tests that measure specific cellular immunity in TB, such as the tuberculin skin test and IFN-g release assays (IGRA). These assays are widely used in Public Health Policy Programs to eliminate the TB epidemic. Quantiferon-TB-Gold-Plus is universally used to diagnosis Latent TB and consists of blood collection tubes containing or not recombinant M. tuberculosis (Mtb) antigens for stimulation of T cells. Decrease of immunity difficult the detection of Mtb specific response by QuantiFERON-TB-Gold, so the search for other biomarkers, soluble, and cellular is actual and important. Several biomarkers are described in the characterization of latent TB, however, the measurement methodologies and immunological functional assays differ from laboratory to laboratory, regarding the use of reagents, design of the assay, lacking a universal standardization for comparing results more effectively. In our laboratory, we propose to use universal methodologies suggested by national and international laboratories that evaluate the immune response to Mtb, either to diagnose Latent TB or to evaluate the immunogenicity of vaccine candidates. For this purpose, we propose the standardization of stimulation of cells with immunodominant antigens present at QuantiFERON-TB-Gold-Plus assay well accepted by the scientific community and immunophenotyping of immune cells using the universal panels. In this project, we will characterize the phenotype of CD4 + T and CD8 + T cells concerning its activation, memory status, Th profile, and exhaustion in the Quantiferon-TB-Gold-Plus assay. The multiple biomarkers characterization in blood immune cells in the IGRA system can help the better diagnosis of Latent TB cases to be prevented treated as recommendations of the Ministry of Health, to avoid TB activation and transmission. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list using this form.